Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Earnings Estimates

Analysts | Earnings Estimates
Glossary
Stock Information
Price (Prev Close):131.97Median Price Target:149.93
Price - 52 Week High149.07Diff from Prev Close:17.96
Price - 52 Week Low103.00% Difference:13.61%
Price Date (Latest):06/14/19  
Analyst Ratings
1-Strong Buy5
2-Buy5
3-Hold7
4-Underperform0
5-Sell0
Mean Recommendation: 2.1

Buy
SellStrong Buy
Available Measures
Analyst Forecasts -
 Last Month Revisions
Fiscal Period MeanHighLowMedian# of Estimates#Up#DownMean % Change
AnnualDec 218.218.627.908.2511000.11
AnnualDec 207.367.967.147.3116000.04
AnnualDec 196.476.506.426.4716000.03
QuarterlyMar 201.611.811.411.61900-0.24
QuarterlyJun 191.561.601.521.5514100.15
QuarterlySep 191.661.721.621.6714000.12
QuarterlyDec 191.841.901.801.851400-0.06
Long Term Growth 11.3714.009.5011.004000.00
Actuals -
  Reported EPSMean EstimateSurprise % Change
AnnualDec 186.035.921.79
AnnualDec 175.275.132.66
AnnualDec 164.564.472.10
QuarterlyMar 191.401.381.33
QuarterlyDec 181.491.406.74
QuarterlySep 181.531.3810.67
QuarterlyJun 181.621.4610.83
Reference Information -
Last Actual (FY0):6.03
FY0 End Date:Dec 18
Hist (5 Yr) Growth %:15.83
Hist (5 Yr) Stability %:--
P/E Ratios
FY0FY1FY2
 Company Industry
P/E RatiosCompanyIndustryInd. Relative
FY021.89----
FY120.40----
FY217.94----
EPS Growth Rates
FY1/FY0FY2/FY1FY3/FY2
 Company Industry
Growth RatesCompanyIndustryInd. Relative
FY1/FY07.29----
FY2/FY113.70----
FY3/FY211.65----

Data Provided by Thomson Reuters
Please note that any opinions, estimates or forecasts regarding Charles River Laboratories International, Inc.'s performance made by the analysts are theirs alone and do not represent opinions, forecasts or predictions of Charles River Laboratories International, Inc. or its management. Charles River Laboratories International, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Stock Quote

CRL (common)
Price
$129.41
Change (%)
- 2.56 (1.94%)
Volume
285,623
Exchange
NYSE
Data as of 06/14/19 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)